Molecular Engineering of Near-Infrared-II Photosensitizers with Steric-Hindrance Effect for Image-Guided Cancer Photodynamic Therapy

The design of photosensitizers (PSs) with fluorescence in the second near-infrared (NIR-II, 1000–1700 nm) window remains a challenge, as the introduction of donor or acceptor units with excessively strong electron-withdrawing or donating ability leads to longer-wavelength emission but insufficient production of singlet oxygen (¹O₂). In this study, a series of acceptor-donor-acceptor-donor-acceptor-type PSs are designed by adjusting the steric hindrance of the molecules. Compound BNET forms a dihedral angle of 88° with a nearly vertically twisted backbone to show that the intensity of local emission in the first near-infrared (750–900 nm) region declines in the aggregated state, while the emission peaks of twisted intramolecular charge transfer span over 1000 nm with significant enhancement. The albumin-bound NIR-II PS nanoparticles exhibit efficient ¹O₂ generation, good photostability and biocompatibility, and negligible dark toxicity. The nanoparticles demonstrate high specific NIR-II fluorescence imaging of tumor lesions as well as effective image-guided photodynamic therapy in mice bearing orthotopic colon cancer or pancreatic cancer. The designed NIR-II PS nanoparticles show great potential for biomedical applications.